FDA Issues Warning Letter to Western Innovations
January 22, 2025
January 22, 2025
WASHINGTON, Jan. 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Western Innovations Inc.:
* * *
To: SJ Jernigan, CEO, Western Innovations, Inc., 4825 Nome St Denver, CO 80239, United States, jerry@westerninnovationsinc.com
Dear Mr. Jernigan:
The U.S. Food and Drug Administration (FDA) conducted an inspection of your facility, located at 4825 Nome Street, Denver, CO, fro . . .
* * *
To: SJ Jernigan, CEO, Western Innovations, Inc., 4825 Nome St Denver, CO 80239, United States, jerry@westerninnovationsinc.com
Dear Mr. Jernigan:
The U.S. Food and Drug Administration (FDA) conducted an inspection of your facility, located at 4825 Nome Street, Denver, CO, fro . . .